These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16296724)

  • 1. Reducing the immunostimulatory activity of CpG-containing plasmid DNA vectors for non-viral gene therapy.
    Yew NS; Cheng SH
    Expert Opin Drug Deliv; 2004 Nov; 1(1):115-25. PubMed ID: 16296724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity of cationic lipid-DNA complexes.
    Yew NS; Scheule RK
    Adv Genet; 2005; 53():189-214. PubMed ID: 16240994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs.
    Yew NS; Zhao H; Wu IH; Song A; Tousignant JD; Przybylska M; Cheng SH
    Mol Ther; 2000 Mar; 1(3):255-62. PubMed ID: 10933941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression.
    Hyde SC; Pringle IA; Abdullah S; Lawton AE; Davies LA; Varathalingam A; Nunez-Alonso G; Green AM; Bazzani RP; Sumner-Jones SG; Chan M; Li H; Yew NS; Cheng SH; Boyd AC; Davies JC; Griesenbach U; Porteous DJ; Sheppard DN; Munkonge FM; Alton EW; Gill DR
    Nat Biotechnol; 2008 May; 26(5):549-51. PubMed ID: 18438402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo evaluation of intrinsic immunogenicity of reporter and insulin gene therapy plasmids.
    Ratanamart J; Huggins CG; Kirby JA; Shaw JA
    J Gene Med; 2007 Aug; 9(8):703-14. PubMed ID: 17595049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of cationic lipid complexed with immunostimulatory DNA.
    Rudginsky S; Siders W; Ingram L; Marshall J; Scheule R; Kaplan J
    Mol Ther; 2001 Oct; 4(4):347-55. PubMed ID: 11592838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of CpG sequences on the B cell response to a viral glycoprotein encoded by a plasmid vector.
    Pasquini S; Deng H; Reddy ST; Giles-Davis W; Ertl HC
    Gene Ther; 1999 Aug; 6(8):1448-55. PubMed ID: 10467369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The administration of naked plasmid DNA into the liver induces antitumor innate immunity in a murine liver metastasis model.
    Yonenaga Y; Mori A; Fujimoto A; Nagayama S; Tachibana T; Onodera H; Uemoto S
    J Gene Med; 2007 Apr; 9(4):299-307. PubMed ID: 17397091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodegradable polymers as non-viral carriers for plasmid DNA delivery.
    Luten J; van Nostrum CF; De Smedt SC; Hennink WE
    J Control Release; 2008 Mar; 126(2):97-110. PubMed ID: 18201788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the content of unmethylated CpG dinucleotides in plasmid DNA on the sustainability of transgene expression.
    Mitsui M; Nishikawa M; Zang L; Ando M; Hattori K; Takahashi Y; Watanabe Y; Takakura Y
    J Gene Med; 2009 May; 11(5):435-43. PubMed ID: 19291673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA and its cationic lipid complexes induce CpG motif-dependent activation of murine dendritic cells.
    Yoshinaga T; Yasuda K; Ogawa Y; Nishikawa M; Takakura Y
    Immunology; 2007 Mar; 120(3):295-302. PubMed ID: 17199803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate immune response induced by gene delivery vectors.
    Sakurai H; Kawabata K; Sakurai F; Nakagawa S; Mizuguchi H
    Int J Pharm; 2008 Apr; 354(1-2):9-15. PubMed ID: 17640834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmidic CpG sequences induce tumor microenvironment modifications in a rat liver metastasis model.
    Bertin S; Anjuere F; Gavelli A; Baque P; Soilihi BK; Brossette N; Loubat A; Pierrefite-Carle V
    Int J Mol Med; 2008 Mar; 21(3):309-15. PubMed ID: 18288378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses to gene therapy vectors: influence on vector function and effector mechanisms.
    Bessis N; GarciaCozar FJ; Boissier MC
    Gene Ther; 2004 Oct; 11 Suppl 1():S10-7. PubMed ID: 15454952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of CpG motifs to the immunogenicity of DNA vaccines.
    Klinman DM; Yamshchikov G; Ishigatsubo Y
    J Immunol; 1997 Apr; 158(8):3635-9. PubMed ID: 9103425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG oligodeoxynucleotides as DNA adjuvants in vertebrates and their applications in immunotherapy.
    Chaung HC
    Int Immunopharmacol; 2006 Oct; 6(10):1586-96. PubMed ID: 16919831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of CpG motifs in endoflagellar gene (flaB2) and expression vector (VR1012) of leptospiral DNA vaccine].
    Dai B; You Z; He P; Wang M; Wang Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jan; 34(1):1-4. PubMed ID: 15600164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs.
    Chen Y; Lenert P; Weeratna R; McCluskie M; Wu T; Davis HL; Krieg AM
    Gene Ther; 2001 Jul; 8(13):1024-32. PubMed ID: 11438837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro assay of immunostimulatory activities of plasmid vectors.
    Jiang W; Reich CF; Pisetsky DS
    Methods Mol Med; 2006; 127():55-70. PubMed ID: 16988446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a recombinant plasmid containing multi-copy CpG motifs and its effects on the innate immune responses of aquatic animals.
    Chen Y; Xiang LX; Shao JZ
    Fish Shellfish Immunol; 2007 Sep; 23(3):589-600. PubMed ID: 17475508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.